共 49 条
[1]
Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, 1, pp. 27-31, (1995)
[2]
Folkman J., Tumor angiogenesis: Therapeutic implications, N Engl J Med, 285, pp. 1182-1186, (1971)
[3]
O'Reilly M.S., Et al., Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma, Cell, 79, pp. 315-328, (1994)
[4]
O'Reilly M.S., Et al., Endostatin: An endogenous inhibitor of angiogenesis and tumor growth, Cell, 88, pp. 277-285, (1997)
[5]
Carmeliet P., Jain R.K., Angiogenesis in cancer and other diseases, Nature, 407, pp. 249-257, (2000)
[6]
Yangopoulos G.D., Davis S., Gale N.W., Et al., Vascular-specific growth factors and blood vessel formation, Nature, 407, pp. 242-248, (2000)
[7]
Kerbel R.S., Tumor angiogenesis: Past, present and the near future, Carcinogenesis, 21, pp. 505-515, (2000)
[8]
Danielsen T., Rofstad E.K., The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts, Br J Cancer, 82, 9, pp. 1528-1534, (2000)
[9]
Dor Y., Porat R., Keshet E., Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis, AJP-Cell Physiol, 280, 6, (2001)
[10]
Ikeda E., Achen M.G., Breier G., Risau W., Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells, J Biol Chem, 270, 34, pp. 19761-19766, (1995)